2. Paragraph 3 of Article 27 of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) provides: "Members may also exclude from patentability: ....
(b) plants and animals other than micro-organisms, and essentially biological processes for the production of plants or animals other than non-biological and microbiological processes. However, Members shall provide for the protection of plant varieties either by patents or by an effective ______system or by any combination thereof…"
(A) Erga omnes
(B) Sui generis
(C) Bona fides
(D) Prima facie

14 Article 27 of the Agreement on Trade-Related Aspects of Intellectual Property Rights provided that “Members may also exclude from patentability:…(b) plants and animals other than micro-organisms, and essentially biological processes for the production of plants or animals other than non-biological and microbiological processes. However, Members shall provide for the protection of plant varieties either by patents or by an effective sui generis system or by any combination thereof.…” What does the phrase “sui generis” mean? (A) Common. (B) Suitable. (C) General. (D) Unique.

3. Under the R.O.C. Patent Act, which of the following patent categories has primary protection on a creation made in respect of the shape, pattern, color, or any combination thereof, of an article as a whole or in part by visual appeal? (A) Invention patent (B) Utility model patent (C) Design patent (D) Art patent

4. According to Article 48-9 of the R.O.C. Pharmaceutical Affair Act, the applicant for a generic drug license shall, with respect to the patent(s) of the approved new drug listed by the said new drug license holder, declare one of the four item(s) in the article when applying for a generic drug license. Which of the following is not a listed item in such article? (A) No patent information on said new drug has been listed. (B) The patent(s) corresponding to said new drug has been extinguished. (C) The central competent health authority will issue the generic drug license after the patent(s) corresponding to said new drug are extinguished. (D) The patent(s) corresponding to said new drugs shall be revoked, or the patent(s) corresponding to the generic drug subject to the application for drug license will not be infringed by said new drugs.

5. Article 13 of the R.O.C. Patent Act provides: "Where the right to apply for a patent is jointly owned,      ①      ….Where one of the owners of the right to apply for a patent abandons his/her own share,      ②      " (A)①each co-owner may freely dispose of his own share.  ②this share shall be assigned to the National Treasury. (B)①each co-owner may freely dispose of his own share. ②this share shall be vested in the other joint owner(s). (C)①the right to apply for the patent shall not be assigned or abandoned without the consent of all joint owners. ②this share shall be assigned to the National Treasury. (D)①the right to apply for the patent shall not be assigned or abandoned without the consent of all joint owners. ②this share shall be vested in the other joint owner(s).

6. Paragraph 1 of Article 97 of the R.O.C. Patent Act provides: "The damages claimed pursuant to the preceding article may be calculated according to any of the following methods: . . .3. the amount calculated on the basis of reasonable _____ that may be collected from exploiting the invention patent being licensed." (A) realties (B) royalties (C) commissions (D) concessions

7. Under the R.O.C. Patent Act, which of the following descriptions is incorrect? (A) Where an invention is made by an employee in the course of performing his duties, the right to apply for a patent and the patent right thereof shall be vested in his employer and the employer shall pay the employee reasonable remuneration; where there is an agreement providing otherwise, such agreement shall prevail. (B) Where a fund provider appoints another party to conduct research and development, the ownership of the right to apply for a patent and the patent right in connection with the outcome of such research and development shall be vested in the party as mutually agreed upon in an agreement between both parties, or such rights shall be vested in the fund provider in the absence of such agreement. (C) Where the ownership of the right to apply for a patent and the patent right are vested in the employer or the fund provider pursuant to Paragraph 1 or Paragraph 3 of Article 7 of the R.O.C. Patent Law, the inventor concerned shall be entitled to have his name shown as such. (D) Where an invention made by an employee has no connection to the course of performing his duties, the right to apply for a patent and the patent right for such invention shall be vested in the employee.

8. According to the R.O.C. Patent Act, which of the following is not a condition under which any person may request an invalidation action against an invention patent with the Specific Patent Agency? (A) The description does not fully disclose the invention in a manner that is clear and sufficient for it to be understood and carried out by a person having ordinary skill in the art. (B) The Chinese translation submitted pursuant to Paragraph 3 of Article 25 extends beyond the scope of content disclosed in the original foreign language documents as filed. (C) A post-grant amendment substantially enlarges or alters the scope of the claim(s) as published. (D) The inventor’s right to be indicated as such is infringed.

9. Under the R.O.C. Patent Act, which of the following conditions does not limit the exclusive rights of patents? (A) Acts done privately and for non-commercial purposes. (B) Research and trials for the purpose of obtaining registration and market approval of drugs under the Pharmaceutical Affairs Act. (C) Producing devices for preparing of medicines in accordance with a prescription from a physician. (D) Where, after the sale of a patented product made by the patentee or made under consent of the patentee, using or reselling such product.

10. Under the R.O.C. Patent Act, which of the following descriptions regarding utility model patent is incorrect? (A)"Utility model" means the conception of technical ideas relating to the shape or structure of an article or combination of articles or processes, utilizing the laws of nature. (B) The term of a utility model patent shall expire after a period of ten years starting from the filing date. (C) When exercising a utility model patent, the patentee shall not make a warning without presenting the technical evaluation report of the utility model patent. (D) Where a utility model patent is revoked, the patentee shall be liable for the damages suffered by another person due to the patentee’s exercise of utility model patent right prior to its revocation. The above shall not apply if such exercise is based on the content of the technical evaluation report of utility model patent and carried out with due care.

11. Company X files a patent infringement action against Company Y before the Intellectual Property and Commercial Court of Taiwan. In response, Company Y asserts that the asserted patent is invalid and presents prior-art evidence. During the litigation, Company X files a post-grant amendment application with the Taiwan Intellectual Property Office (TIPO), and the amendment proceeding remains pending.  Under the R.O.C. Intellectual Property Case Adjudication Act, which of the following statements is MOST accurate? (A) The court must stay the infringement action until TIPO and all subsequent administrative appeal proceedings regarding the amendment become final. (B) The court may not determine whether the patent has grounds for invalidation because such issues fall exclusively within TIPO's jurisdiction. (C) The court may independently determine whether the patent has grounds for invalidation and may consider the potential effect of the pending amendment without necessarily waiting for TIPO's final decision. (D) The court may determine patent validity, but it is prohibited from considering any amendment that has not yet been approved by TIPO.

115年 - 115 專技高考_專利師（選試專業英文及工程力學）、專利師（選試專業英文及生物技術）、專利師（選試專業英文及電子學）、專利師（選試專業英文及物理化學）、專利師（選試專業英文及工業設計）、專利師（選試專業英文及計算機結構）：專業英文#143698

114年 - 114 專技高考_專利師（選試專業英文及工程力學）、專利師（選試專業英文及生物技術）、專利師（選試專業英文及電子學）、專利師（選試專業英文及物理化學）、專利師（選試專業英文及工業設計）、專利師（選試專業英文及計算機結構）：專業英文#130109

113年 - 113 專技高考_專利師（選試專業英文及工程力學）、專利師（選試專業英文及生物技術）、專利師（選試專業英文及電子學）、專利師（選試專業英文及物理化學）、專利師（選試專業英文及工業設計）、專利師（選試專業英文及計算機結構）：專業英文#122217

112年 - 112 專技高考_專利師（選試專業英文及工程力學）、專利師（選試專業英文及生物技術）、專利師（選試專業英文及電子學）、專利師（選試專業英文及物理化學）、專利師（選試專業英文及工業設計）、專利師（選試專業英文及計算機結構）：專業英文#116256

111年 - 111 專技高考_專利師（選試專業英文及工程力學）、專利師（選試專業英文及生物技術）、專利師（選試專業英文及電子學）、專利師（選試專業英文及物理化學）、專利師（選試專業英文及工業設計）、專利師（選試專業英文及計算機結構）：專業英文#110450

110年 - 110 專技高考_專利師（選試專業英文及工程力學）、專利師（選試專業英文及生物技術）、專利師（選試專業英文及電子學）、專利師（選試專業英文及物理化學）、專利師（選試專業英文及工業設計）、專利師（選試專業英文及計算機結構）：專業英文#100754

109年 - 109 專技高考_專利師（選試專業英文及工程力學）、專利師（選試專業英文及生物技術）、專利師（選試專業英文及電子學）、專利師（選試專業英文及物理化學）、專利師（選試專業英文及工業設計）、專利師（選試專業英文及計算機結構）：專業英文#90223

108年 - 108 專技高考_專利師（選試專業英文及工程力學）、專利師（選試專業英文及生物技術）、專利師（選試專業英文及電子學）、專利師（選試專業英文及物理化學）、專利師（選試專業英文及工業設計）、專利師（選試專業英文及計算機結構）：專業英文#78683

107年 - 107 專技高考_專利師（選試專業英文及工程力學）、專利師（選試專業英文及生物技術）、專利師（選試專業英文及電子學）、專利師（選試專業英文及物理化學）、專利師（選試專業英文及工業設計）、專利師（選試專業英文及計算機結構）：專業英文#71646

106年 - 106 專技高考_專利師（選試專業英文及工程力學）、專利師（選試專業英文及生物技術）、專利師（選試專業英文及電子學）、專利師（選試專業英文及物理化學）、專利師（選試專業英文及工業設計）、專利師（選試專業英文及計算機結構）：專業英文#64361